{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T09:43:36Z","timestamp":1775555016585,"version":"3.50.1"},"reference-count":24,"publisher":"Stanford University Press","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Mass Spectrometry and Advances in the Clinical Lab"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jmsacl.2024.01.001","type":"journal-article","created":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T02:51:06Z","timestamp":1705114266000},"page":"27-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Bioanalysis of bedaquiline in human plasma by liquid chromatography-tandem mass spectrometry: Application to pharmacokinetic study"],"prefix":"10.21627","volume":"31","author":[{"given":"Viritha","family":"Bezawada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Padma","family":"Mogili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivasa","family":"Rao Polagani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9315-9085","authenticated-orcid":false,"given":"Sireesha","family":"Dodda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4811","reference":[{"key":"10.1016\/j.jmsacl.2024.01.001_b0005","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4103\/0022-3859.138772","article-title":"Bedaquiline: a novel antitubercular drug for multidrug-resistant tuberculosis","volume":"60","author":"Nagabushan","year":"2014","journal-title":"J Postgrad Med."},{"key":"10.1016\/j.jmsacl.2024.01.001_b0010","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4103\/2278-344X.187830","article-title":"Bedaquiline: a new hope in treatment of tuberculosis","volume":"5","author":"Singh","year":"2016","journal-title":"Int J Health Allied Sci."},{"key":"10.1016\/j.jmsacl.2024.01.001_b0015","first-page":"FM01","article-title":"Bedaquiline: a novel antitubercular agent for the treatment of multidrug resistant tuberculosis","volume":"10","author":"Yadav","year":"2016","journal-title":"J Clin Diagn Res."},{"key":"10.1016\/j.jmsacl.2024.01.001_b0020","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5005\/jp-journals-10085-8101","article-title":"Bedaquiline: a mini review","volume":"8","author":"Saravanabavan","year":"2019","journal-title":"Ann. SBV"},{"key":"10.1016\/j.jmsacl.2024.01.001_b0025","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1183\/13993003.00724-2015","article-title":"Bedaquiline in the treatment of multidrug and extensively drug resistant tuberculosis","volume":"47","author":"Pym","year":"2016","journal-title":"Eur Respir J."},{"key":"10.1016\/j.jmsacl.2024.01.001_b0030","doi-asserted-by":"crossref","first-page":"11902","DOI":"10.1039\/C8RA00984H","article-title":"Bedaquiline has potential for targeting tuberculosis reservoirs in the central nervous system","volume":"8","author":"Annapurna","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.jmsacl.2024.01.001_b0035","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2217\/fmb.10.50","article-title":"TMC207: the first compound of a new class of potent anti-tuberculosis drugs","volume":"5","author":"Matteelli","year":"2010","journal-title":"Future Microbiol."},{"key":"10.1016\/j.jmsacl.2024.01.001_b0040","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1093\/jac\/dku171","article-title":"Bedaquiline: A review of human pharmacokinetics and drug-drug interactions","volume":"69","author":"Van","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jmsacl.2024.01.001_b0045","doi-asserted-by":"crossref","first-page":"6934","DOI":"10.1021\/acsomega.0c06165","article-title":"Effect of Disease State on the Pharmacokinetics of Bedaquiline in Renal-Impaired and Diabetic Rats","volume":"6","author":"Abhishek","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.jmsacl.2024.01.001_b0050","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5588\/ijtld.22.0326","article-title":"Comparison of pharmacokinetics and bioavailability of bedaquiline fumarate, benzoate and maleate in dogs","volume":"27","author":"Jaw-Tsai","year":"2023","journal-title":"Int J Tuberc Lung Dis."},{"key":"10.1016\/j.jmsacl.2024.01.001_b0055","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.5588\/ijtld.17.0408","article-title":"An LC-MS\/MS-based method to analyze the anti-tuberculosis drug bedaquiline in hair","volume":"21","author":"Metcalfe","year":"2017","journal-title":"Int J Tuberc Lung Dis."},{"key":"10.1016\/j.jmsacl.2024.01.001_b0060","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jchromb.2019.02.022","article-title":"Assessment of preclinical drug interactions of bedaquiline by a highly sensitive LC-ESI-MS\/MS based bioanalytical method","volume":"1112","author":"Kotwal","year":"2019","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"key":"10.1016\/j.jmsacl.2024.01.001_b0065","first-page":"1319","article-title":"Determination of bedaquiline plasma concentration by high performance liquid chromatography-mass spectrometry\/mass spectrometry","volume":"40","author":"Hui","year":"2018","journal-title":"Chin. J. Antituberculosis."},{"key":"10.1016\/j.jmsacl.2024.01.001_b0070","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1111\/bcp.13696","article-title":"Relative bioavailability of bedaquiline tablets suspended in water: Implications for dosing in children","volume":"84","author":"Svensson","year":"2018","journal-title":"Br J Clin Pharmacol."},{"key":"10.1016\/j.jmsacl.2024.01.001_b0075","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/QAI.0b013e3182410503","article-title":"ACTG 5267 Study Team. Safety, tolerability, and pharmacokinetic interactions of the antituberculous agent TMC207 (bedaquiline) with efavirenz in healthy volunteers: AIDS Clinical Trials Group Study A5267","volume":"59","author":"Dooley","year":"2012","journal-title":"J Acquir Immune Defic Syndr."},{"key":"10.1016\/j.jmsacl.2024.01.001_b0080","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1128\/AAC.00276-15","article-title":"Determination of bedaquiline in human serum using liquid chromatography-tandem mass spectrometry","volume":"59","author":"Alffenaar","year":"2015","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.jmsacl.2024.01.001_b0085","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/jac\/dkv447","article-title":"Drug-drug interactions between bedaquiline and the antiretrovirals lopinavir\/ritonavir and nevirapine in HIV-infected patients with drug-resistant TB","volume":"71","author":"Pandie","year":"2016","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.jmsacl.2024.01.001_b0090","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1128\/AAC.01204-07","article-title":"Early bactericidal activity and pharmacokinetics of the diarylquinoline TMC207 in treatment of pulmonary tuberculosis","volume":"52","author":"Rustomjee","year":"2008","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.jmsacl.2024.01.001_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2019.07.023","article-title":"Development and validation of an LC-MS\/MS method for the simultaneous determination of bedaquiline and rifabutin in human plasma","volume":"176","author":"Gray","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jmsacl.2024.01.001_b0100","first-page":"36","article-title":"Simultaneous method for the estimation of bedaquiline and delamanid in human plasma using High-Performance Liquid Chromatography","volume":"13","author":"Hemanth","year":"2021","journal-title":"Int J Pharm Pharm Sci"},{"key":"10.1016\/j.jmsacl.2024.01.001_b0105","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1021\/ac302919t","article-title":"Comparative analysis of sample preparation methods to handle the complexity of the blood fluid metabolome: When less is more","volume":"85","author":"Tulipani","year":"2013","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jmsacl.2024.01.001_b0110","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Veterinary Medicine (CVM). May 2018 Bioanalytical Method Validation Guidance for Industry Available at:https:\/\/www.fda.gov\/media\/70858."},{"issue":"165","key":"10.1016\/j.jmsacl.2024.01.001_b0115","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jpba.2018.11.056","article-title":"High sensitive LC-MS\/MS method for estimation of eluxadoline in human plasma and its application to pharmacokinetic study","volume":"20","author":"Dodda","year":"2019","journal-title":"J Pharm Biomed Anal."},{"key":"10.1016\/j.jmsacl.2024.01.001_b0120","unstructured":"World Health Organization. July 2021. Notes on the design of bioequivalence study: Bedaquiline. Available at: https:\/\/extranet.who.int\/pqweb\/key-resources\/documents\/notes-design-bioequivalence-study-bedaquiline."}],"container-title":["Journal of Mass Spectrometry and Advances in the Clinical Lab"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667145X24000014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667145X24000014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:22:45Z","timestamp":1767770565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667145X24000014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":24,"alternative-id":["S2667145X24000014"],"URL":"https:\/\/doi.org\/10.1016\/j.jmsacl.2024.01.001","relation":{},"ISSN":["2667-145X"],"issn-type":[{"value":"2667-145X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioanalysis of bedaquiline in human plasma by liquid chromatography-tandem mass spectrometry: Application to pharmacokinetic study","name":"articletitle","label":"Article Title"},{"value":"Journal of Mass Spectrometry and Advances in the Clinical Lab","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmsacl.2024.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 THE AUTHORS. Publishing services by ELSEVIER B.V. on behalf of MSACL.","name":"copyright","label":"Copyright"}]}}